Profile
Genestack provides a platform to manage and integrate life sciences data for AI and research applications.
Genestack, founded in 2012 by Dr. Misha Kapushesky, a former group leader at the European Bioinformatics Institute, specializes in life sciences data management. The company emerged as a joint venture with JetBrains, focusing on solving data science challenges in R&D.
Its flagship product, Open Data Manager (ODM), launched in 2019, integrates multimodal life sciences data into a queryable, governed asset. Genestack serves top biopharma, agriscience, and academic institutions, with clients like Bayer, AstraZeneca, and the Sanger Institute. Recent efforts emphasize AI integration, particularly in harmonizing data for agentic AI applications. The company is actively participating in industry events like the 2026 Data + AI Summit, signaling its focus on AI-ready data infrastructure.
Who buys this
- Top biopharmaceutical companies
- Agricultural science enterprises
- Academic and research institutions
- Consumer goods companies with R&D focus
- Clinical research organizations
Publicly disclosed clients
- Bayer
- AstraZeneca
- Sanger Institute
- Unilever
- Corteva
- City University of New York
Strengths and what to watch
Strengths
- Strong client base in top-tier biopharma and agriscience
- Focus on FAIR (Findable, Accessible, Interoperable, Reusable) data principles
- Integration of AI and LLMs for data harmonization and insights
Watch for
- Dependence on large enterprise clients in a niche market
- Competition from broader data platform providers expanding into life sciences
- Challenges in scaling AI integration across diverse data types
Recent moves
Key Information
- Founded
- 2012
Frequently Asked Questions
What is Genestack and what does it do?
Genestack is a life sciences data management platform founded in 2012 by Dr. Misha Kapushesky. It helps biopharma, agriscience, and research institutions integrate multimodal data for AI and research applications, with a focus on FAIR (Findable, Accessible, Interoperable, Reusable) data principles. (42 words)
What is Genestack's Open Data Manager?
Open Data Manager (ODM) is Genestack's flagship product launched in 2019. It transforms diverse life sciences data into queryable, governed assets. ODM helps organizations harmonize research data across modalities, making it AI-ready while maintaining compliance with data governance standards. (44 words)
How does Genestack integrate AI with life sciences data?
Genestack focuses on structuring life sciences data for AI applications, particularly agentic AI. Its platform harmonizes multimodal data to enable machine learning, with recent collaborations like AstraZeneca demonstrating AI-ready data fabric implementations for pharmaceutical research. (42 words)
Which companies use Genestack's platform?
Genestack serves top biopharma (Bayer, AstraZeneca), agriscience (Corteva), academic (Sanger Institute, CUNY), and consumer goods (Unilever) organizations. Its client base reflects strong adoption among enterprises needing to manage complex life sciences R&D data at scale. (45 words)
What are Genestack's main competitive advantages?
Genestack differentiates through its life sciences specialization, FAIR data implementation, and AI-readiness focus. Its joint venture origins with JetBrains provide strong technical foundations, while partnerships with top biopharma validate its enterprise capabilities in sensitive research environments. (45 words)
What challenges does Genestack face in the market?
Genestack competes with broader data platforms expanding into life sciences while serving a niche enterprise market. Scaling AI integration across diverse data types remains challenging, though its participation in events like the 2026 Data + AI Summit shows continued innovation focus. (46 words)
Sources
- genestack.com — Company founding and mission
- genestack.com — Recent AI integration efforts
- genestack.com — Collaboration with CUNY
- genestack.com — Product details